Dyadic International announces collaboration with leading animal health company

Dyadic International Inc (NASDAQ: DYAI) CEO Mark Emalfarb sat down with Proactive’s Steve Darling at the 12th annual LD Micro Conference in Bel Air, California. Dyadic, based in Jupiter, Florida, leverages its proprietary C1 technology — an industrially proven fungal gene expression technology — to help bring biologic vaccines, enzymes, proteins, biosimilars, and drugs to market faster and at a lower cost.

Post Author: hatefull